LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.01
 15.58 27.76 560 685 0.8168 0.9144
MN20160318_Q01
J07
MCF 10A-H2B-mCherry Dasatinib
0.01
 15.58 27.76 1427 685 2.0815 1.3434
MN20160318_Q01
J07
MCF 10A-H2B-mCherry Dasatinib
0.01
 17.28 27.76 619 838 0.7380 0.8802
MN20160318_Q01
E09
MCF 10A-H2B-mCherry Dasatinib
0.01
 17.28 27.76 1064 838 1.2686 1.0992
MN20160318_Q01
E09
MCF 10A-H2B-mCherry Dasatinib
0.01
 17.28 27.76 1169 838 1.3938 1.1397
MN20160318_Q01
J07
MCF 10A-H2B-mCherry Dasatinib
0.01
 17.28 27.76 1509 838 1.7992 1.2537
MN20160318_Q01
J07
MCF 10A-H2B-mCherry Dasatinib
0.01
 18.98 27.76 789 941 0.8383 0.9318
MN20160318_Q01
E09
MCF 10A-H2B-mCherry Dasatinib
0.01
 18.98 27.76 1147 941 1.2187 1.0794
MN20160318_Q01
E09
MCF 10A-H2B-mCherry Dasatinib
0.01
 18.98 27.76 1467 941 1.5587 1.1825
MN20160318_Q01
J07
MCF 10A-H2B-mCherry Dasatinib
0.01
 18.98 27.76 1663 941 1.7670 1.2370
MN20160318_Q01
J07
MCF 10A-H2B-mCherry Dasatinib
0.01
 20.68 27.76 1109 1119 0.9911 0.9966
MN20160318_Q01
E09
MCF 10A-H2B-mCherry Dasatinib
0.01
 20.68 27.76 1253 1119 1.1197 1.0429
MN20160318_Q01
E09
MCF 10A-H2B-mCherry Dasatinib
0.01
 20.68 27.76 1703 1119 1.5219 1.1639
MN20160318_Q01
J07
MCF 10A-H2B-mCherry Dasatinib
0.01
 20.68 27.76 1837 1119 1.6416 1.1948
MN20160318_Q01
J07
MCF 10A-H2B-mCherry Dasatinib
0.01
 22.39 27.76 1265 1305 0.9688 0.9886
MN20160318_Q01
E09
MCF 10A-H2B-mCherry Dasatinib
0.01
 22.39 27.76 1354 1305 1.0370 1.0131
MN20160318_Q01
E09
MCF 10A-H2B-mCherry Dasatinib
0.01
 22.39 27.76 1899 1305 1.4544 1.1395
MN20160318_Q01
J07
MCF 10A-H2B-mCherry Dasatinib
0.01
 22.39 27.76 2002 1305 1.5333 1.1599
MN20160318_Q01
J07
MCF 10A-H2B-mCherry Dasatinib
0.01
 24.09 27.76 1381 1461 0.9448 0.9803
MN20160318_Q01
E09
MCF 10A-H2B-mCherry Dasatinib
0.01
 24.09 27.76 1456 1461 0.9961 0.9987
MN20160318_Q01
E09
MCF 10A-H2B-mCherry Dasatinib
0.01
 24.09 27.76 2020 1461 1.3820 1.1164
MN20160318_Q01
J07
MCF 10A-H2B-mCherry Dasatinib
0.01
 24.09 27.76 2108 1461 1.4422 1.1323
MN20160318_Q01
J07
MCF 10A-H2B-mCherry Dasatinib
0.01
 25.79 27.76 1499 1605 0.9339 0.9768
MN20160318_Q01
E09
MCF 10A-H2B-mCherry Dasatinib
0.01
 25.79 27.76 1560 1605 0.9719 0.9903
MN20160318_Q01
E09
MCF 10A-H2B-mCherry Dasatinib
0.01
 25.79 27.76 2235 1605 1.3924 1.1164
MN20160318_Q01
J07